Omnicell Inc OMCL:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:01 PM EST
123.60UNCH (UNCH)
Volume
47,917
Close
123.60quote price arrow down-0.77 (-0.62%)
Volume
234,213
52 week range
54.24 - 137.99

...

Loading . . .

KEY STATS

  • Open124.31
  • Day High125.13
  • Day Low121.95
  • Prev Close124.37
  • 52 Week High137.99
  • 52 Week High Date02/02/21
  • 52 Week Low54.24
  • 52 Week Low Date03/20/20
  • Market Cap5.32B
  • Shares Out43.04M
  • 10 Day Average Volume0.26M
  • Dividend-
  • Dividend Yield-
  • Beta1.04
  • 1 Year % Change48.99

RATIOS/PROFITABILITY

  • EPS (TTM)0.73
  • P/E (TTM)168.83
  • Fwd P/E (NTM)35.09
  • EBITDA (MRQ)106.449M
  • ROE (MRQ)3.55%
  • Revenue (MRQ)892.21M
  • Gross Margin (MRQ)46.60%
  • Net Margin (MRQ)3.61%
  • Debt To Equity (MRQ)48.29%

EVENTS

  • Earnings Date05/05/2021
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Omnicell Inc News

There is no recent news for this security.

Latest OMCL News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
Omnicell, Inc. provides automation and business analytics software solutions for patient-centric medication and supply management across the entire healthcare continuum, from the acute care hospital setting to post-acute skilled nursing and long-term care facilities to the home. It operates through two segments: Automation and Analytics, and Medication Adherence. The Automation and Analytics segment is engaged in the design, manufacturing, selling and servicing of medication...
Randall Lipps
Chairman
Peter Kuipers
Chief Financial Officer
Scott Seidelmann
Executive Vice President
Daniel Johnston J.D.
Executive Vice President
Address
590 E Middlefield Rd
Mountain View, CA
94043-4008
United States